Recombinant anti-osteopontin antibody and use thereof
Details for Australian Patent Application No. 2002332290 (hide)
International Classifications
Event Publications
6 February 2003 Complete Application Filed
Priority application(s): 2001-290700 25.09.01 JP
26 June 2003 Application Open to Public Inspection
Published as AU-B-2002332290
2 March 2006 Assignment before Grant
Immuno-Biological Laboratories Co., Ltd.; Fujisawa Pharmaceutical Co., Ltd The application has been assigned to Immuno-Biological Laboratories Co., Ltd.; Astellas Pharma Inc.
30 November 2006 Assignment before Grant
Immuno-Biological Laboratories Co; Ltd The application has been assigned to Astellas Pharma Inc.; Juridical Foundation the Chemo-sero-therapeutic Research Institute
8 November 2007 Application Accepted
Published as AU-B-2002332290
6 March 2008 Alteration of Name
The name of the patentee has been altered to Juridical Foundation The Chemo-Sero-Therapeutic Research Institute; Astellas Pharma Inc.
6 March 2008 Standard Patent Sealed
23 April 2009 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired
This patent ceased under section 143(a), or Expired. Note that applications or patents shown as lapsed or ceased may be restored at a later date.
Legal
The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.
Next and Previous Patents/Applications
2002332291-CONNECTOR FOR HIGH-RATE TRANSMISSION
2002332289-Diaryl sulfide derivative, addition salt thereof, and immunosppressant
IP Reporting Samples
Customised IP Reporting
IP Insider for IP Professionals
IP Monitor Professional
- Editable Word format reports
- For IP Professionals
- Multiuser